Physicochemical characterization and cytotoxicity of articaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Authors: Burga-Sanchez, Jonny; Ferreira, Luiz Eduardo Nunes; Volpato, Maria Cristina; Cabeca, Luis Fernando; Braga, Mario; Fraceto, Leonardo Fernandes; de Paula, Eneida; Groppo, Francisco Carlos
Abstract
Articaine (ATC) is one of the most widely used local anesthetics in dentistry. Despite its safety, local toxicity has been reported. This study aimed to develop an ATC-2- hydroxypropyl-beta-cyclodextrin inclusion complex (ATC HP beta CD) and to assess its toxicity in vitro. The inclusion complex was performed by solubilization, followed by a fluorimetric and job plot assay to determine the complex stoichiometry. Scanning electron microscopy, DOSY- 1 H-NMR, differential scanning calorimetry (DSC), and sustained release kinetics were used to confirm the inclusion complex formation. In vitro cytotoxicity was analyzed by MTT assay and immunofluorescence in HGF cells. Fluorimetric and job plot assay determined the inclusion complex stoichiometry (ATC:HP beta CD = 1:1) and complex formation time (400 min), as indicated by a strong host/guest interaction (K-a = 117.8 M - 1), complexed fraction (f = 41.4%), and different ATC and ATC HP beta CD melting points (172 degrees C e 235 degrees C, respectively). The mean of cell viability was 31.87% and 63.17% for 20-mM ATC and 20-mM ATC HP beta CD, respectively. Moreover, remarkable cell toxicity was observed with free ATC by immunofluorescence. These results indicate the ATC HP beta CD complex could be used to improve the safety of ATC. Further research are needed to establish the anesthetic safety and effectiveness in vivo .
Glutathione catabolism by Treponema denticola impacts its pathogenic potential
ANAEROBE
Authors: Chu, Lianrui; Wu, Yimin; Xu, Xiaoping; Phillips, Linda; Kolodrubetz, David
Abstract
Treponema denticola is a spirochete that is etiologic for periodontal diseases. This bacterium is one of two periodontal pathogens that have been shown to have a complete three step enzymatic pathway (GTSP) that catabolizes glutathione to H2S. This pathway may contribute to the tissue pathology seen in periodontitis since diseased periodontal pockets have lower glutathione levels than healthy sites with a concomitant increase in H2S concentration. In order to be able to demonstrate that glutathione catabolism by the GTSP is critical for the pathogenic potential of T. denticola, allelic replacement mutagenesis was used to make a deletion mutant (Delta g gt) in the gene encoding the first enzyme in the GTSP. The mutant cannot produce H2S from glutathione since it lacks gamma-glutamyltransferase (GGT) activity. The hemolytic and hemoxidation activities of wild type T. denticola plus glutathione are reduced to background levels with the Delta ggt mutant and the mutant has lost the ability to grow aerobically when incubated with glutathione. The ggt bacteria with glutathione cause less cell death in human gingival fibroblasts (hGFs) in vitro than do wild type T. denticola and the levels of hGF death correlate with the amounts of H2S produced. Importantly, the mutant spirochetes plus glutathione make significantly smaller lesions than wild type bacteria plus glutathione in a mouse back lesion model that assesses soft tissue destruction, a major symptom of periodontal diseases. Our results are the first to prove that T. denticola thiol-compound catabolism by its gamma-glutamyltransferase can play a significant role in the in the types of host tissue damage seen in periodontitis. (C) 2020 Elsevier Ltd. All rights reserved.